2,000+ startups will be exhibiting at this week’s Collision Conference but only 70 have been selected to PITCH onstage live.
PITCH is Collision’s startup competition that brings together the world’s leading early-stage startups to battle it out onstage.
Among the 70 lucky startups to get stage time in Toronto is four that call British Columbia home.
myMomentum | Vancouver | ALPHA
myMomentum is a fun, easy platform that connects, actives & engages people within their communities and companies. By uniting the world through wellness, we enable people to live happier & healthier.
Cheer on myMomentum’s CEO Anna Chan on Tuesday, June 27th at 10am EST at part of PITCH Group 2 and visit them in booth A540 on Wednesday, June 28th.
Orgmatch | Vancouver | ALPHA
Orgmatch’s mission is to make finding and deploying funding in the nonprofit sector affordable, fast, and fair. We believe technology can be used to reduce the burden on nonprofits to find and secure funding while ensuring the diligence needs of funders are met.
Cheer on Orgmatch’s CEO and Co-founder Trevor Loke on Tuesday, June 27th at 11am EST at part of PITCH Group 3 and visit them in booth A604 on Thursday, June 29th.
DYNE | Vancouver | BETA
DYNE is a business-to-business startup that specializes in providing in-depth analytics to the restaurant industry. Freshly funded, DYNE plans to further develop its analytics platform, which helps restaurants analyze sales, inventory, and customer data while providing recommendations to help restaurants make better-informed decisions.
Cheer on DYNE’s Regional Manager Mani Panahandeh on Tuesday, June 27th at 3pm EST at part of PITCH Group 10 and visit them in booth B604 on Thursday, June 29th.
VoxCell BioInnovation | Victoria | BETA
Named one of Techcouver’s 10 Homegrown Startups to Watch in 2023, VoxCell BioInnovation is creating vascularized, human-like cancer tissue models by combining a custom high-resolution 3D bioprinter, advanced software, and proprietary bio-inks. VoxCell aims to accelerate the development of life-saving anti-cancer drugs by providing tissue models that can identify viable candidates earlier in the drug-development pipeline.
Cheer on VoxCell BioInnovation’s CEO Dr. Karolina Valente on Tuesday, June 27th at 2pm EST at part of PITCH Group 8 and visit them in booth B501 on Wednesday, June 28th.
Note: The startups that exhibit at Collision are assigned to a category depending on the company size and revenue.
ALPHA startups are in the pre-investment stage or have under $1 million in funding. BETA startups have launched successfully, found a market fit, and are generating revenue. GROWTH startups have raised over $3 million and are experiencing considerable growth and expanding globally.
Leave a Reply